AWP Reform Debate Continues; U.S. Oncology Says Cut Will Hit Profits In ‘05
U.S. Oncology expects that the transition from AWP-based reimbursement to ASP-based reimbursement will reduce Medicare payments to oncologists by approximately 8% in 2005
U.S. Oncology expects that the transition from AWP-based reimbursement to ASP-based reimbursement will reduce Medicare payments to oncologists by approximately 8% in 2005